Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Changes in conversational pattern as a clinical trial outcome: a proof-of-concept study using the I-CONECT data.

Innovation in aging·2026
Same author

How loneliness and social isolation are linked to cognitive decline among older adults? A systematic review of underlying physiological and psychobehavioral mechanisms.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Prevalence, risk factors, and management of adult asthma in Taipei, Taiwan: A global asthma network study.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Methodological challenges in evaluating high-dose ICS escalation.

The journal of allergy and clinical immunology. In practice·2026
Same author

Sjögren's Disease in Transition: Advances in Pathogenesis, Diagnosis, and Targeted Therapy.

International journal of rheumatic diseases·2026
Same author

Digital Phenotyping via Passive Network Traffic Monitoring: Prospective Observational Study in University Students.

JMIR formative research·2026
Same journal

Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Greater choroid plexus volume is linked to poor sleep, neurodegeneration, and cognitive deficits in older adults: Evidence from the IGNITE Study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Plasma-based neurobiological protein biomarkers as predictors of dementia progression: Insights from longitudinal aging study in India - Diagnostic assessment of dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Neuropathology-specific language features in primary progressive aphasia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Dementia blood biomarkers in the context of post-stroke cognitive outcomes: Systematic review and evidence synthesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

Chao-Yi Wu1, Liu Chen1, Steven E Arnold1

  • 1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Los gemelos digitales creados a partir de datos existentes mejoran los ensayos controlados aleatorizados (ECA) para la demencia temprana al proporcionar controles virtuales. Este método mejora el rigor del ensayo y ofrece una evaluación personalizada del tratamiento sin grupos de placebo controvertidos.

Palabras clave:
gemelos digitalesensayos clínicosdemenciacontroles virtualesensayos controlados aleatorizadosevaluación personalizadatratamientoplaceboinvestigaciónneurocienciaensayos clínicosbiotecnología

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Área de la Ciencia:

  • Neurociencia; Ensayos Clínicos; Biotecnología

Sus antecedentes:

  • Surgen preocupaciones éticas con el uso de placebo en ensayos de demencia debido a nuevos tratamientos aprobados por la FDA.
  • La tecnología de gemelos digitales (control virtual) ofrece un enfoque personalizado para evaluar los efectos del tratamiento.
  • La viabilidad de las técnicas de gemelos digitales en la investigación clínica sigue sin explorarse en gran medida.

Objetivo del estudio:

  • Evaluar la viabilidad y eficacia del uso de gemelos digitales como controles en ensayos clínicos de demencia en fase temprana.
  • Comparar la efectividad de los métodos de control de gemelos digitales frente a los diseños tradicionales de ensayos controlados aleatorizados (ECA).
  • Evaluar el impacto de las interacciones conversacionales en la cognición en adultos mayores utilizando gemelos digitales.

Principales métodos:

  • Un ensayo controlado aleatorizado (ECA) que involucró a 186 participantes de ≥75 años con cognición normal o deterioro cognitivo leve.
  • Se generaron gemelos digitales utilizando datos del National Alzheimer's Coordinating Center-Uniform Data Set (NACC-UDS) a través de mapeo de gemelos y modelado de bosque aleatorio.
  • Se compararon los resultados cognitivos (MoCA, CFA) entre los datos del ensayo original y los controles de gemelos digitales en el seguimiento de 6 meses.

Principales resultados:

  • Los tamaños del efecto del tratamiento para MoCA y CFA en diseños de grupos paralelos se alinearon estrechamente entre los ensayos originales y los de control con gemelos digitales.
  • Para los diseños n-of-1, ambos métodos de gemelos digitales mostraron una concordancia sustancial en la identificación de respondedores al tratamiento.
  • Aproximadamente el 10% de los participantes de NACC-UDS fueron elegibles para generar gemelos digitales.

Conclusiones:

  • Los gemelos digitales derivados de conjuntos de datos públicos pueden mejorar significativamente el rigor de los ECA de demencia en fase temprana.
  • Este enfoque proporciona una alternativa válida a los grupos de control tradicionales, lo que permite la evaluación personalizada del tratamiento.
  • La tecnología de gemelos digitales muestra una gran promesa para mejorar el diseño y las consideraciones éticas de la investigación sobre la demencia.